Opioids for cancer-related pain in children and adolescents

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 2, 2017, Pages

  Wiffen, Philip J ^a   Cooper, Tess E ^b   Anderson, Anna Karenia ^c   Gray, Andrew L ^d   Grégoire, Marie Claude ^e   Ljungman, Gustaf ^f   Zernikow, Boris ^g,h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UPPSALA UNIVERSITY   (Sweden)

^g Children's and Adolescents' Hospital   (Germany)

^h UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ANALGESIA; ARTICLE; CANCER PAIN; CHILD; HUMAN; INFANT; META ANALYSIS (TOPIC); NUMERIC RATING SCALE; OUTCOME ASSESSMENT; PAIN INTENSITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; VISUAL ANALOG SCALE; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ANALGESICS, OPIOID; CANCER PAIN; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN;

EID: 85013424298     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012564     Document Type: Article

References (56)

1. American Cancer Society. Cancer in children. www.cancer.org/cancer/cancerinchildren/detailedguide/cancer-in-children-types-of-childhood-cancers (accessed July 2016) 2015.
2. American Medical Association. Paediatric pain management. Pain management www.ama-cmeonline.com/pain_mgmt/printversion/ama_painmgmt_m6.pdf (accessed 25 January 2016) 2013.
3. Cochrane Pain, Palliative and Supportive Care Group. PaPaS author and referee guidance. papas.cochrane.org/papas-documents (accessed 16 July 2016) 2012.
4. Caes L, Boemer KE, Chambers CT, Campbell-Yeo M, Stinson J, Birnie KA, et al. A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010. Pain 2016;157(2):302-13. DOI: 10.1097/j.pain.0000000000000403
5. Cooper TE, Fisher E, Gray A, Krane E, Sethna NF, van Tilburg M, et al. Opioids for chronic non-cancer pain in children and adolescents. Cochrane Database of Systematic Reviews 2017, Issue 2. DOI: 10.1002/14651858.CD012538
6. Cooper TE, Heathcote L, Clinch J, Gold J, Howard R, Lord S, et al. Antidepressants for chronic non-cancer pain in children and adolescents. Cochrane Database of Systematic Reviews 2017, Issue 2. DOI: 10.1002/14651858.CD012535
7. Cooper TE, Heathcote L, Anderson B, Gregoire MC, Ljungman G, Eccleston C. Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents. Cochrane Database of Systematic Reviews 2017, Issue 2. DOI: 10.1002/14651858.CD012563
8. Cooper TE, Fisher E, Anderson B, Wilkinson N, Williams G, Eccleston C. Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents. Cochrane Database of Systematic Reviews 2017, Issue 2. DOI: 10.1002/14651858.CD012539
9. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105-21. DOI: 10.1016/j.jpain.2007.09.005
10. Eccleston C, Malleson PM. Management of chronic pain in children and adolescents (Editorial). BMJ 2003;326:1408-9.
11. Eccleston C, Cooper TE, Fisher E, Anderson B, Wilkinson N. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. Cochrane Database of Systematic Reviews 2017, Issue 2. DOI: 10.1002/14651858.CD012537
12. Frankish H. 15 million new cancer cases per year by 2020, says WHO. Lancet 2003;361:1278.
13. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. DOI: 10.1136/bmj.39489.470347.AD
14. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE Guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64:383-94. DOI: 10.1016/j.jclinepi.2010.04.026
15. Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coelle P, et al. Making an overall rating of the confidence in effect estimates for a single outcome and for all outcomes. Journal of Clinical Epidemiology 2013;66(2):151-7. DOI: 10.1016/j.jclinepi.2012.01.006
16. Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. Journal of Clinical Epidemiology 2013;66(2):158-72. DOI: 10.1016/j.jclinepi.2012.01.012
17. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration.
18. Hoffman DL, Sadosky A, Dukes EM, Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?. Pain 2010;149(2):194-201. DOI: 10.1016/j.pain.2009.09.017
19. International Association on the Research of Cancer. Global cancer facts & figures. www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf (accessed 7 March 2016) 2008.
20. Kaatsch P. Epidemiology of childhood cancer. Cancer Treatment Reviews 2010;36(4):277-85. DOI: 10.1016/ctrv.2010.02.003
21. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33.
22. Ljungman G, Kreuger A, Gordh T, Berg T, Sorensen S, Rawal N. Treatment of pain in paediatric oncology: a Swedish nationwide survey. Pain 1996;68:385-94.
23. McQuay H, Moore R. An Evidence-based Resource for Pain Relief. Oxford (UK): Oxford University Press, 1998.
24. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097.
25. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle (WA): IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5
26. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. DOI: 10.1002/14651858.CD007076.pub2
27. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. "Evidence" in chronic pain - establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9. DOI: 10.1016/j.pain.2010.05.011
28. Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ. Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010;149(2):360-4.
29. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374-9. DOI: 10.1136/ard.2009.107805
30. Moore RA, Smugar SS, Wang H, Peloso PM, Gammaitoni A. Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials. Pain 2010;151(3):592-7. DOI: 10.1016/j.pain.2010.07.2013
31. Moore RA, Straube S, Paine J, Derry S, McQuay HJ. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011;152(5):982-9. DOI: 10.1016/j.pain.2010.11.030
32. Moore RA, Mhuircheartaigh RJ, Derry S, McQuay HJ. Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion. European Journal of Anaesthesiology 2011;28(6):427-32. DOI: 10.1097/EJA.0b013e328343c569
33. Moore RA, Straube S, Eccleston C, Derry S, Aldington D, Wiffen P, et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 2012;153(2):265-8. DOI: 10.1016/j.pain.2011.10.004
34. Moore RA, Straube S, Aldington D. Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome. Anaesthesia 2013;68(4):400-12. DOI: 10.1111/anae.12148
35. Moore A, Derry S, Eccleston C, Kalso E. Expect analgesic failure; pursue analgesic success. BMJ 2013;346:f2690. DOI: 10.1136/bmj.f2690
36. Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice 2014;14(1):79-94.
37. Moore RA, Cai N, Skljarevski V, Tölle TR. Duloxetine use in chronic painful conditions--individual patient data responder analysis. European Journal of Pain 2014;18(1):67-75. DOI: 10.1002/j.1532-2149.2013.00341.x
38. O'Brien EM, Staud RM, Hassinger AD, McCulloch RC, Craggs JG, Atchinson JW, et al. Patient-centered perspective on treatment outcomes in chronic pain. Pain Medicine 2010;11(1):6-15. DOI: 10.1111/j.1526-4637.2009.00685.x
39. Twycross R, Wilcock A, Howard P. Palliative care formulary. Palliativedrugs.com (accessed September 2016) 2014.
40. McGrath PJ, Walco GA, Turk DC, Dworking RH, Brown MT, Davidson K, et al. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT. Journal of Pain 2008;9(9):771-83.
41. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
42. Ripamonti C, Bandieri E. Pain therapy. Oncology/Hematology 2008;70:145-59. DOI: 10.1016/j.critrevonc.2008.12.005
43. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Experimental and Clinical Psychopharmacology 2008;16(5):405-16. DOI: 10.1037/a0013628
44. Stinson JN, Kavanagh T, Yamada J, Gill N, Stevens B. Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain 2006;125(1-2):143-57. DOI: 10.1016/j.pain.2006.05.006
45. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. British Journal of Clinical Pharmacology 2008;66(2):266-75. DOI: 10.1111/j.1365-2125.2008.03200.x
46. Straube S, Derry S, Moore RA, Paine J, McQuay HJ. Pregabalin in fibromyalgia--responder analysis from individual patient data. BMC Musculoskeletal Disorders 2010;11:150. DOI: 10.1186/1471-2474-11-150
47. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology 2008;8:29. DOI: 10.1186/1471-2377-8-29
48. Tanko NM, Echejoh GO, Manasseh NA, Mandong MB, Uba AF. Paediatric solid tumours in Nigerian children: a changing pattern. African Journal of Pediatric Surgery 2009;6:7-10.
49. World Bank. Data - population ages 0-14 (% of total). data.worldbank.org/indicator/SP.POP.0014.TO.ZS (accessed 29 February 2016) 2014.
50. United Nations. World population prospects 2015 - population indicators. esa.un.org/unpd/wpp/Download/Standard/Population/ (accessed 29 February 2016) 2015.
51. Verghese ST, Hannallah RS. Acute pain management in children. Journal of Pain Reseaerch 2010;3:105-23. DOI: 10.2147/JPR.S4554
52. von Bayer CL, Spagrud LJ. Systematic review of observational (behavioural) measures of pain for children and adolescents aged 3 to 18 years. Pain 2007;127(1-2):140-50. DOI: 10.1016/j.pain.2006.08.014
53. World Health Organisation. Cancer pain relief and palliative care in children. WHO Library Cataloguing in Publication Data 1998.
54. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. WHO Press, World Health Organization 2012. [ISBN 978 92 4 154812 0
55. World Health Organisation. Cancer fact sheet N°297. www.who.int/mediacentre/factsheets/fs297/en/ (accessed 26 February 2016) 2015.
56. Wiffen PJ, Cooper TE, Heathcote L, Clinch J, Howard R, Krane E, et al. Antiepileptic drugs for chronic non-cancer pain in children and adolescents. Cochrane Database of Systematic Reviews 2017, Issue 2. DOI: 10.1002/14651858.CD012536